Author Question: If a product's price increases, then its: a. MP will increase. b. MFC will increase. c. MRP will ... (Read 7 times)

imowrer

  • Hero Member
  • *****
  • Posts: 514
If a product's price increases, then its:
 a. MP will increase.
  b. MFC will increase.
  c. MRP will increase.
  d. MP will decrease.

Question 2

Which of the following is true at the point where diminishing returns set in?
 a. Both marginal product and marginal cost are at a maximum.
  b. Both marginal product and marginal cost are at a minimum.
  c. Marginal product is at a maximum and marginal cost at a minimum.
  d. Marginal product is at a minimum and marginal cost at a maximum.



lorealeza

  • Sr. Member
  • ****
  • Posts: 345
Answer to Question 1

c

Answer to Question 2

c



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

In 1885, the Lloyd Manufacturing Company of Albany, New York, promoted and sold "Cocaine Toothache Drops" at 15 cents per bottle! In 1914, the Harrison Narcotic Act brought the sale and distribution of this drug under federal control.

Did you know?

Walt Disney helped combat malaria by making an animated film in 1943 called The Winged Scourge. This short film starred the seven dwarfs and taught children that mosquitos transmit malaria, which is a very bad disease. It advocated the killing of mosquitos to stop the disease.

Did you know?

Elderly adults are at greatest risk of stroke and myocardial infarction and have the most to gain from prophylaxis. Patients ages 60 to 80 years with blood pressures above 160/90 mm Hg should benefit from antihypertensive treatment.

Did you know?

About 60% of newborn infants in the United States are jaundiced; that is, they look yellow. Kernicterus is a form of brain damage caused by excessive jaundice. When babies begin to be affected by excessive jaundice and begin to have brain damage, they become excessively lethargic.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library